# VEGF as a Prognostic Factor for White Matter Damage in Preterm Infants

> **NCT00564161** · — · WITHDRAWN · sponsor: **Hadassah Medical Organization**

## Conditions studied

- Preterm Infants With White Matter Damage
- Preterm Infants Developing Normally

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00564161
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-01
- **Primary completion:** —
- **Final completion:** 2009-01
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2016-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00564161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00564161, "VEGF as a Prognostic Factor for White Matter Damage in Preterm Infants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00564161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*